Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
By simultaneously targeting multiple pathways, impairing mitochondrial function, and engaging immune mechanisms, this strategy is defining the core framework of next-generation precision therapies for CRC
285 Metabolic and epigenetic reprogramming enables pentanoate and butyrate to enhance the effectiveness of cancer immunotherapy by boosting the antitumor activity of antigen-specific cytotoxic T lymphocytes and ROR1-targeting chimeric antigen receptor (CAR)-T cells
a , Hydroxylation of C 2 would preclude the incorporation of an O 18 label as no equilibrium between a ketone and a gem-diol form exists for this hydroxylation product
10.1016/j.pmpp.2015.09.001 71 HoG
US$ 22.50
US$ 20.66
US$ 21.20
US$ 29.95
